References
- Huang M.E., Ye Y.C., Chen S.R., Chai J.R., Lu J.X., Zhao L., Gu L.J., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
- Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger S., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–1709
- Chen Z.X., Xue Y.Q., Zhang R., Tao R.F., Xia X.M., Li C., Wang W., Zu W.Y., Yao X.Z., Ling B.J. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413–1419
- Fenaux P., Castaigne S., Chomienne C., Dombret H., Degos L. All-trans retinoic acid treatment for patients with acute promyelocytic leukemia. Leukemia 1991; 6: 64–67
- Castaigne S., Chomienne C., Fenaux P., Daniel M.T., Degos L. Hyperleukocytosis during all-trans retinoic acid for acute promyelocytic leukemia. Blood 1991; 76(Suppl. 1)260a
- Frankel S.R., Eardley A., Lauwers G., Weiss M., Warrell R.P., Jr. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann. Intern. Med. 1992; 117: 292–296
- Warrell R.P., Jr, Frankel S.R., Miller W.H., Scheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M.S., Dimitrowsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 1991; 324: 1385–1393
- Warrell R.P., Jr, Frankel S.R., Miller W.H., Eardley A., Dimitrowski E. All-trans retinoic acid for remission induction of acute promyelocytic leukemia: results of the New York study. Blood 1992; 80(Suppl. 1)360a
- Dombret H., Sutton L., Duarte M., Daniel M.T., Leblond V., Castaigne S., Degos L. Combined therapy with all-trans retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia 1992; 6: 1237–1242
- Fenaux P., Robert M.C., Castaigne S., Archimbaud E., Chomienne C., Link H., Guerci A., Bowen D., Sanz M., Fey M., Fegueux N., Chastang C., Degos L. A multicenter trial comparing all-trans retinoic acid plus chemotherapy (ATRA+CT) and CT alone in newly diagnosed acute promyelocytic leukemia (APL). Proc. 29th Ann. Meeting of the Am. Soc. Clin. Oncol. 1993; 12–300
- Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemias. Ann. Intern. Med. 1985; 103: 626–633
- Douer D., Koeffler H.P. Retinoic acid enhances colony stimulating factor-induced clonal growth of human myeloid progenitor cells in vitro. Exp. Cell Res. 1982; 138: 193–197
- Van Bockstaele D.R., Lenjou M., Snoeck H.W., Lardon F., Stryckmans P., Peetermans M.E. Direct effect of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: Comparative study on BM mononuclear cells and on isolated CD 34+ BM cells. Ann. HematoL 1993; 66: 61–66
- Sakashita A., Kizaki M., Pakkala S., Schiller G., Tsu-Ruoka N., Tomosaki R., Cameron J.F., Dawson M.I., Koeffler H.P. 9-cis-Retinoic acid: Effects on normal and leukemic hematopoiesis in vitro. Blood 1993; 81: 1009–1016
- Visani G., Cenacchi A., Tosi P., Finelli C., Fogli M., Gamberi B., Martinelli G., Tura S. All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: A case report. Br. J. Haematol. 1992; 81: 444–448